NPR

Antibody Drugs For COVID-19 Are A Cumbersome Tool Against Surges

Drugs that can help keep COVID-19 patients out of the hospital are playing only a small role in Michigan, where the pandemic is accelerating. Logistical challenges are to blame.

Government officials are trying to figure out how to make better use of drugs that can keep people with COVID-19 out of the hospital. That's an urgent but daunting challenge in Michigan, where hospitals are struggling to keep up with a surge in new cases.

Monoclonal antibodies can hold the coronavirus in check by mimicking the body's natural immune defenses. The drugs, produced by Regeneron and Eli Lilly, can keep people with mild to moderate COVID-19 out of the hospital and have emergency authorization for people over 65, as well as others with certain underlying health conditions.

On Wednesday, Michigan Gov. Gretchen Whitmer urged people in her

Stai leggendo un'anteprima, registrati per continuare a leggere.

Altro da NPR

NPR2 min lettiSecurity
Cybersecurity Attack Shuts Down A Top U.S. Gasoline Pipeline
An attack shuts down Colonial Pipeline, a major transporter of gasoline along the East Coast. A security analyst says the event shows the vulnerability of key elements of the nation's infrastructure.
NPR2 min lettiMedical
Ramping Up Its COVID Response, EU Will Buy Up To 1.8B Doses Of Pfizer Vaccine
The agreement provides a significant boost to the European Union's goal of getting 70% of adults vaccinated. Currently, around a quarter of the bloc's population is vaccinated.
NPR3 min letti
Elon Musk Hosts SNL
Tesla CEO Elon Musk hosted Saturday Night Live this weekend, alongside musical guest Miley Cyrus — how did he do?